Gary C.W. Chan

1.3k total citations
37 papers, 585 citations indexed

About

Gary C.W. Chan is a scholar working on Nephrology, Epidemiology and Rheumatology. According to data from OpenAlex, Gary C.W. Chan has authored 37 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 6 papers in Epidemiology and 6 papers in Rheumatology. Recurrent topics in Gary C.W. Chan's work include Renal Diseases and Glomerulopathies (11 papers), Chronic Kidney Disease and Diabetes (10 papers) and Systemic Lupus Erythematosus Research (5 papers). Gary C.W. Chan is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Chronic Kidney Disease and Diabetes (10 papers) and Systemic Lupus Erythematosus Research (5 papers). Gary C.W. Chan collaborates with scholars based in Hong Kong, China and United States. Gary C.W. Chan's co-authors include Sydney Tang, Tak Mao Chan, Desmond Y. H. Yap, Lorraine Pui Yuen Kwan, Colin Tang, Sriram Krishnaswami, Kam Wa Chan, Kar Neng Lai, Wai Han Yiu and Chi Yuen Cheung and has published in prestigious journals such as Frontiers in Immunology, Transplantation and Nephrology Dialysis Transplantation.

In The Last Decade

Gary C.W. Chan

37 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary C.W. Chan Hong Kong 15 211 172 110 82 79 37 585
Patricia Sorroche Argentina 16 56 0.3× 99 0.6× 81 0.7× 101 1.2× 68 0.9× 58 626
Peter Thye‐Rønn Denmark 12 68 0.3× 270 1.6× 75 0.7× 110 1.3× 19 0.2× 26 730
Ivo Lukitsch United States 7 164 0.8× 43 0.3× 121 1.1× 93 1.1× 23 0.3× 12 644
Graciela Delgado Austria 14 322 1.5× 63 0.4× 109 1.0× 169 2.1× 19 0.2× 28 731
Yusuf Selçoki Türkiye 13 370 1.8× 85 0.5× 33 0.3× 106 1.3× 22 0.3× 41 718
H. A. Bock Switzerland 15 237 1.1× 44 0.3× 65 0.6× 121 1.5× 46 0.6× 28 748
Chris Rivard United States 11 322 1.5× 49 0.3× 64 0.6× 151 1.8× 20 0.3× 21 660
Jin Sug Kim South Korea 16 229 1.1× 58 0.3× 92 0.8× 147 1.8× 11 0.1× 76 722
An-Hang Yang Taiwan 13 173 0.8× 43 0.3× 59 0.5× 168 2.0× 15 0.2× 30 694
Shuiming Guo China 12 61 0.3× 69 0.4× 74 0.7× 86 1.0× 13 0.2× 19 384

Countries citing papers authored by Gary C.W. Chan

Since Specialization
Citations

This map shows the geographic impact of Gary C.W. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary C.W. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary C.W. Chan more than expected).

Fields of papers citing papers by Gary C.W. Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary C.W. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary C.W. Chan. The network helps show where Gary C.W. Chan may publish in the future.

Co-authorship network of co-authors of Gary C.W. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Gary C.W. Chan. A scholar is included among the top collaborators of Gary C.W. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary C.W. Chan. Gary C.W. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Benjamin, Tianze Sun, Liwen Wu, et al.. (2025). Content Analysis of the Portrayal of Prescription Stimulants on TikTok. Journal of Attention Disorders. 29(8). 617–627. 1 indexed citations
2.
Chan, Kam Wa, Alfred Siu Kei Kwong, Gary C.W. Chan, et al.. (2024). Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trial. Phytomedicine. 130. 155457–155457. 12 indexed citations
3.
Chan, Kam Wa, et al.. (2023). Long-term outcomes of add-on direct renin inhibition in igA nephropathy: a propensity score-matched cohort study. Journal of Nephrology. 36(2). 407–416. 3 indexed citations
4.
5.
Yap, Desmond Y. H., Philip H. Li, Colin Tang, et al.. (2021). Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis. Kidney International Reports. 7(3). 516–525. 14 indexed citations
6.
Chan, Kam Wa, Gary C.W. Chan, Wai Han Yiu, et al.. (2020). Patients’ and clinicians’ expectations on integrative medicine Services for Diabetes: a focus group study. BMC Complementary Medicine and Therapies. 20(1). 205–205. 10 indexed citations
7.
Yap, Desmond Y. H., et al.. (2018). Longterm Data on Sirolimus Treatment in Patients with Lupus Nephritis. The Journal of Rheumatology. 45(12). 1663–1670. 53 indexed citations
8.
Yap, Desmond Y. H., et al.. (2017). Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years. The Journal of Rheumatology. 44(9). 1375–1383. 37 indexed citations
9.
Yap, Desmond Y. H., Wai Kay Seto, James Fung, et al.. (2016). Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis. Digestive and Liver Disease. 49(2). 202–206. 21 indexed citations
10.
Cheung, Chi Yuen, Gary C.W. Chan, Flora Ng, et al.. (2016). Cancer Incidence and Mortality in Chronic Dialysis Population: A Multicenter Cohort Study. American Journal of Nephrology. 43(3). 153–159. 38 indexed citations
11.
12.
Chan, Gary C.W. & Sydney Tang. (2015). Diabetic nephropathy: landmark clinical trials and tribulations. Nephrology Dialysis Transplantation. 31(3). 359–368. 79 indexed citations
13.
Chan, Gary C.W., Wai Han Yiu, Hao Wu, et al.. (2015). N‐Acetyl‐seryl‐aspartyl‐lysyl‐proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice. Mediators of Inflammation. 2015(1). 283123–283123. 10 indexed citations
14.
Chan, Gary C.W., Bing Lam, Desmond Y. H. Yap, et al.. (2015). Proteinuria is associated with sleep apnea in chronic kidney disease. Nephrology Dialysis Transplantation. 31(5). 772–779. 8 indexed citations
15.
Yap, Desmond Y. H., Susan Yung, Colin Tang, et al.. (2014). Entecavir treatment in kidney transplant recipients infected with hepatitis B. Clinical Transplantation. 28(9). 1010–1015. 15 indexed citations
16.
Yap, Desmond Y. H., et al.. (2014). Long-term data on tacrolimus treatment in lupus nephritis. Lara D. Veeken. 53(12). 2232–2237. 40 indexed citations
17.
Yap, Desmond Y. H., et al.. (2014). Chronotropic incompetence, echocardiographic abnormalities and exercise intolerance in renal transplant recipients. Journal of Nephrology. 27(4). 451–456. 2 indexed citations
18.
Chan, Gary C.W., Anskar Y.H. Leung, Kwok Wah Chan, et al.. (2012). Quantification of BK Viral Load in Asymptomatic Renal Allograft Recipients. Renal Failure. 34(5). 550–554. 3 indexed citations
19.
Lamba, Manisha, Bashir Akhavan Tafti, Marc L. Melcher, et al.. (2010). Population Pharmacokinetic Analysis of Mycophenolic Acid Coadministered With Either Tasocitinib (CP-690,550) or Tacrolimus in Adult Renal Allograft Recipients. Therapeutic Drug Monitoring. 32(6). 778–781. 13 indexed citations
20.
Lawendy, Nervin, Sriram Krishnaswami, Rong Wang, et al.. (2009). Effect of CP‐690,550, an Orally Active Janus Kinase Inhibitor, on Renal Function in Healthy Adult Volunteers. The Journal of Clinical Pharmacology. 49(4). 423–429. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia Sorroche Breakdown of academic impact, for papers by Peter Thye‐Rønn Breakdown of academic impact, for papers by Ivo Lukitsch Breakdown of academic impact, for papers by Graciela Delgado Breakdown of academic impact, for papers by Yusuf Selçoki Breakdown of academic impact, for papers by H. A. Bock Breakdown of academic impact, for papers by Chris Rivard Breakdown of academic impact, for papers by Jin Sug Kim Breakdown of academic impact, for papers by An-Hang Yang Breakdown of academic impact, for papers by Shuiming Guo
Rankless by CCL
2026